RIGGS RORY B 1016835 Data last updated 2025-02-01 06:40:02 -0600 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | 2024-02-20 | 4 | Riggs Rory B | DIRECTOR | acq | 300000.0 | 93.72 | 6.72 | 0.0 | Direct | Class A Ordinary Shares | ROYALTY PHARMA PLC | code C | 320099.0 | 446.69 (RPRX) |
| 2024-02-22 | 2024-02-20 | 4 | Riggs Rory B | DIRECTOR | holding | 85187.0 | 0 | 1.91 | 0.0 | By New Ventures Iii Llc | Class A Ordinary Shares | ROYALTY PHARMA PLC | NA | 446.69 (RPRX) | ||
| 2024-02-22 | 2024-02-20 | 4 | Riggs Rory B | DIRECTOR | holding | 15000.0 | 0 | 0.34 | 0.0 | By Spouse | Class A Ordinary Shares | ROYALTY PHARMA PLC | NA | 446.69 (RPRX) | ||
| 2024-03-22 | 2024-03-20 | 2024-03-20 | 4 | Riggs Rory B | DIRECTOR | acq | 20000.0 | 20.15 | 2.07 | 18.56 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code M | 99235.0 | 96.81 (ITCI) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Riggs Rory B | DIRECTOR | acq | 260.0 | 0.26 | 0.03 | 69.2 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code A | 99495.0 | 96.81 (ITCI) |
| 2024-06-14 | 2024-06-11 | 2024-06-11 | 4 | Riggs Rory B | CEO | acq | 98040.0 | 3.06 | 45.5 | 10.2 | Direct | Class A Common Stock | CIBUS, INC. | code A | 3201828.0 | 21.55 (CBUS) |
| 2024-06-14 | 2024-06-11 | 4 | Riggs Rory B | CEO | holding | 15791.0 | 0 | 7.33 | 0.0 | By Spouse | Class A Common Stock | CIBUS, INC. | NA | 21.55 (CBUS) | ||
| 2024-06-14 | 2024-06-11 | 4 | Riggs Rory B | CEO | holding | 2916.0 | 0 | 1.35 | 0.0 | The Rory Riggs Family Trust | Class A Common Stock | CIBUS, INC. | NA | 21.55 (CBUS) | ||
| 2024-06-25 | 2024-06-23 | 2024-06-24 | 4 | Riggs Rory B | DIRECTOR | dsp | 4462.0 | 3.69 | 0.42 | 75.57 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code S | 116600.0 | 105.57 (ITCI) |
| 2024-06-25 | 2024-06-23 | 2024-06-23 to 2024-06-24 | 4 | Riggs Rory B | DIRECTOR | acq | 21567.0 | 17.81 | 2.04 | 15.63 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code M | 121062.0
|
105.57 (ITCI) |
| 2024-07-02 | 2024-06-28 | 2024-06-28 | 4 | Riggs Rory B | DIRECTOR | acq | 262.0 | 0.22 | 0.02 | 68.49 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code A | 116862.0 | 105.57 (ITCI) |
| 2024-09-20 | 2024-09-18 | 2024-09-18 | 4 | Riggs Rory B | CEO | acq | 250000.0 | 7.24 | 108.28 | 4.0 | Direct | Class A Common Stock | CIBUS, INC. | code A | 3451828.0 | 23.09 (CBUS) |
| 2024-09-20 | 2024-09-18 | 4 | Riggs Rory B | CEO | holding | 2916.0 | 0 | 1.26 | 0.0 | The Rory Riggs Family Trust | Class A Common Stock | CIBUS, INC. | NA | 23.09 (CBUS) | ||
| 2024-09-20 | 2024-09-18 | 4 | Riggs Rory B | CEO | holding | 15791.0 | 0 | 6.84 | 0.0 | By Spouse | Class A Common Stock | CIBUS, INC. | NA | 23.09 (CBUS) | ||
| 2024-10-02 | 2024-09-30 | 2024-09-30 | 4 | Riggs Rory B | DIRECTOR | acq | 246.0 | 0.21 | 0.02 | 73.17 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code A | 117108.0 | 105.67 (ITCI) |
| 2024-10-15 | 2019-06-18 | 2019-06-18 | 4 | Riggs Rory B | DIRECTOR | acq | 14189.0 | 10.81 | 1.34 | 0.0 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code M | 131297.0 | 105.67 (ITCI) |
| 2025-01-03 | 2024-12-31 | 2024-12-31 | 4 | Riggs Rory B | DIRECTOR | acq | 215.0 | 0.16 | 0.02 | 83.52 | Direct | Common Stock | INTRA-CELLULAR THERAPIES, INC. | code A | 131512.0 | 106.02 (ITCI) |
| 2025-01-10 | 2024-12-31 | 2024-12-31 | 4 | Riggs Rory B | CEO | dsp | 1388084.0 | 100.0 | 4459.68 | 0.0 | Direct | Class B Common Stock | CIBUS, INC. | code C | 0.0 | 3.11 (CBUS) |
| 2025-01-10 | 2024-12-31 | 2024-12-31 | 4 | Riggs Rory B | CEO | acq | 1388084.0 | 28.68 | 524.68 | 0.0 | Direct | Class A Common Stock | CIBUS, INC. | code C | 4839912.0 | 26.46 (CBUS) |
| 2025-01-10 | 2024-12-31 | 4 | Riggs Rory B | CEO | holding | 15791.0 | 0 | 5.97 | 0.0 | By Spouse | Class A Common Stock | CIBUS, INC. | NA | 26.46 (CBUS) | ||
| 2025-01-10 | 2024-12-31 | 4 | Riggs Rory B | CEO | holding | 2916.0 | 0 | 1.1 | 0.0 | The Rory Riggs Family Trust | Class A Common Stock | CIBUS, INC. | NA | 26.46 (CBUS) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | 2024-02-20 | 4 | Riggs Rory B | DIRECTOR | dsp | 30000.0 | 10.0 | 0.67 | 0.0 | Direct | Lp Interests In Rpi Us Partners 2019, Lp | ROYALTY PHARMA PLC | code C | 270000.0 | 446.69 (RPRX) |
| 2024-03-22 | 2024-03-20 | 2024-03-20 | 4 | Riggs Rory B | DIRECTOR | dsp | 20000.0 | 100.0 | 2.07 | 18.56 | Direct | Stock Option (Right To Buy) | INTRA-CELLULAR THERAPIES, INC. | code M | 0.0 | 96.81 (ITCI) |
| 2024-06-14 | 2024-06-11 | 2024-06-11 | 4 | Riggs Rory B | CEO | acq | 98040.0 | 100.0 | 45.5 | 10.07 | Direct | Common Warrant | CIBUS, INC. | code A | 98040.0 | 21.55 (CBUS) |
| 2024-06-18 | 2024-06-14 | 2024-06-14 | 4 | Riggs Rory B | DIRECTOR | acq | 4322.0 | 100.0 | 0.41 | 67.77 | Direct | Stock Option (Right To Buy) | INTRA-CELLULAR THERAPIES, INC. | code A | 4322.0 | 105.57 (ITCI) |
| 2024-06-18 | 2024-06-14 | 2024-06-14 | 4 | Riggs Rory B | DIRECTOR | acq | 2951.0 | 100.0 | 0.28 | 0.0 | Direct | Restricted Stock Units | INTRA-CELLULAR THERAPIES, INC. | code A | 2951.0 | 105.57 (ITCI) |
| 2024-06-25 | 2024-06-23 | 2024-06-24 | 4 | Riggs Rory B | DIRECTOR | dsp | 20000.0 | 100.0 | 1.89 | 16.86 | Direct | Stock Option (Right To Buy) | INTRA-CELLULAR THERAPIES, INC. | code M | 0.0 | 105.57 (ITCI) |
| 2024-06-25 | 2024-06-23 | 2024-06-23 | 4 | Riggs Rory B | DIRECTOR | dsp | 1567.0 | 100.0 | 0.15 | 0.0 | Direct | Restricted Stock Units | INTRA-CELLULAR THERAPIES, INC. | code M | 0.0 | 105.57 (ITCI) |
| 2024-10-15 | 2019-06-18 | 2019-06-18 | 4 | Riggs Rory B | DIRECTOR | dsp | 14189.0 | 100.0 | 1.34 | 0.0 | Direct | Restricted Stock Units | INTRA-CELLULAR THERAPIES, INC. | code M | 0.0 | 105.67 (ITCI) |
| 2025-01-10 | 2024-12-31 | 2024-12-31 | 4 | Riggs Rory B | CEO | dsp | 1388084.0 | 100.0 | 524.68 | 0.0 | Direct | Cibus Common Unit | CIBUS, INC. | code C | 0.0 | 26.46 (CBUS) |
| 2025-01-23 | 2025-01-21 | 2025-01-21 | 4 | Riggs Rory B | CEO | acq | 4000000.0 | 100.0 | 1511.97 | 2.5 | Direct | Pre Funded Warrant | CIBUS, INC. | code A | 4000000.0 | 26.46 (CBUS) |
| 2025-01-23 | 2025-01-21 | 2025-01-21 | 4 | Riggs Rory B | CEO | acq | 4000000.0 | 100.0 | 1511.97 | 2.5 | Direct | Common Warrant | CIBUS, INC. | code A | 4000000.0 | 26.46 (CBUS) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)